Avalo Therapeutics Inc. (AVTX)
Market Closed
17 Jul, 20:00
$
19. 37
+1.49
+8.3333%
$
216.96M Market Cap
- P/E Ratio
- Div Yield
1.24M Volume
- Eps
$ 17.88
Previous Close 
Want to track AVTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalo Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Farallon Capital Farallon Capital Management LLC | 916,000 | $13.68M | $16.94M | $3.26M | 23.84% |
 Point72 Asset Management LP Point72 Asset Management LP | 916,142 | $12.28M | $16.86M | $4.57M | 37.22% |
| SE Sima Elimelech Activest Wealth Management | 1 | $12.47 | $18.55 | $6.08 | 48.76% |
| EY Ellen York T. Rowe Price Investment Management Inc. | 2.16M | $32.29M | $40.21M | $7.92M | 24.53% |
| RG Robert Glass AlphaCentric Advisors LLC | 11,668 | $174,203.24 | $217,374.84 | $43,171.6 | 24.78% |
| DP Drew Phillips Fortitude Family Office LLC | 63 | $941 | $1,158.57 | $217.57 | 23.12% |
 Kevin Roan Stempoint Capita LLP | 134,742 | $2.45M | $2.5M | $51,202.28 | 2.09% |
| AA Andrew Alkon EntryPoint Capital, LLC | 30,041 | $448,512 | $545,917.07 | $97,405.07 | 21.72% |
 Christopher C. Powers Farther Finance Advisors, LLC | 75 | $1,119.75 | $1,452.75 | $333 | 29.74% |
 David Vollmer PFS Partners, LLC | 2,000 | $30,870 | $36,221.2 | $5,351.2 | 17.33% |
 BRIANNE SHERGILL Exome Asset Management LLC | 159,341 | $2.38M | $2.87M | $495,948.99 | 20.85% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 7,918 | $143,790.92 | $148,224.96 | $4,434.04 | 3.08% |
